```html

Acne Vulgaris – A Complete Medical Guide

Overview

Acne vulgaris is a chronic inflammatory skin disorder that primarily affects the pilosebaceous units (hair follicles and their associated oil glands). It is the most common skin condition worldwide, with CDC estimates that up to 85% of adolescents and 40–50% of adults experience at least mild acne at some point in their lives.

While acne is most frequent during puberty (ages 12‑19), it can occur in early childhood, pregnancy, and even in the elderly. The condition does not discriminate by gender, but hormonal fluctuations mean females may see flare‑ups around menstrual cycles, while males often have more severe lesions during late adolescence.

In the United States, acne accounts for roughly 15 million outpatient visits per year — a public‑health burden comparable to asthma and diabetes combined (NIH, 2023).

Symptoms

Acne lesions vary in size, depth, and appearance. Commonly affected sites include the face, neck, chest, shoulders, and upper back.

Typical lesions

• Comedones – non‑inflamed plugs: open comedones (blackheads) and closed comedones (whiteheads).
• Papules – small, raised, red bumps without pus.
• Pustules – inflamed papules filled with yellow‑white pus.
• Nodules – large, painful, solid lesions deep in the dermis.
• Cysts – fluid‑filled pockets that can rupture, leading to scarring.

Associated symptoms

• Tenderness or pain, especially with nodules/cysts.
• Redness and swelling of the surrounding skin.
• Post‑inflammatory hyperpigmentation (dark spots) after lesions heal.
• Potential for permanent scarring (ice‑pick, rolling, or hypertrophic scars).

Causes and Risk Factors

Acne is multifactorial. The primary pathophysiologic steps include:

1. Follicular hyperkeratinisation – excess keratin blocks the pore.
2. Increased sebum production – driven by androgens.
3. Colonisation by Cutibacterium acnes (formerly Propionibacterium acnes) – bacterial overgrowth triggers inflammation.
4. Inflammatory response – immune cells release cytokines that swell the follicle.

Key risk factors

• Hormonal changes – puberty, menstrual cycle, polycystic ovary syndrome (PCOS), pregnancy, or hormonal contraceptives.
• Genetics – having a first‑degree relative with severe acne raises risk 2‑3 fold (J Am Acad Dermatol, 2021).
• Medications – corticosteroids, anabolic steroids, lithium, and some antiepileptics.
• Dietary influences – high‑glycemic load foods and dairy may exacerbate lesions in susceptible individuals (Mayo Clinic, 2022).
• Mechanical irritation – friction from helmets, tight clothing, or frequent touching of the face.
• Stress – can worsen inflammation via cortisol pathways.

Diagnosis

Acne is primarily a clinical diagnosis made by visual inspection. No laboratory tests are required in most cases, but certain evaluations can help rule out mimickers or assess severity.

Clinical assessment

• Physical examination of the distribution and type of lesions.
• Severity grading (e.g., the Global Acne Grading System or the Leeds Acne Score) to guide therapy.

When additional tests may be ordered

• Hormone panels – if acne is severe, late‑onset, or accompanied by hirsutism/irregular menses.
• Skin swab or culture – rarely, to exclude atypical bacterial infection.
• Biopsy – in cases suspicious for acneiform eruptions secondary to other dermatologic diseases (e.g., lupus).

Treatment Options

Treatment is individualized based on severity, location, patient age, skin type, and risk of scarring. Early, aggressive therapy for moderate‑to‑severe acne reduces the chance of permanent marks.

Topical Therapies

• Retinoids (tretinoin, adapalene, tazarotene) – normalize keratinocyte shedding; first‑line for comedonal acne.
• Topical antibiotics (clindamycin, erythromycin) – reduce C. acnes load; should be combined with benzoyl peroxide to minimize resistance.
• Benzoyl peroxide – bactericidal and anti‑inflammatory; available 2.5‑10%.
• Azelaic acid – keratolytic, antibacterial, and useful for post‑inflammatory hyperpigmentation.
• Dapsone gel – anti‑inflammatory; approved for inflammatory lesions.

Systemic Medications

• Oral antibiotics (doxycycline, minocycline, tetracycline, erythromycin) – for moderate inflammatory acne; typically 3–6 months.
• Hormonal therapy (combined oral contraceptives, spironolactone) – effective in females with hormonal acne.
• Isotretinoin – oral retinoid for severe, nodulocystic acne or acne refractory to other treatments. Requires strict pregnancy‑prevention program (iPLEDGE in the U.S.).
• Antibiotic stewardship – limit systemic antibiotics to ≤ 3‑4 months to reduce resistance.

Procedural Options

• Chemical peels (salicylic acid, glycolic acid) – exfoliate and reduce comedones.
• Light and laser therapies – blue‑light, photodynamic therapy, or pulsed‑dye laser target C. acnes and inflammation.
• Intralesional corticosteroid injection – rapid resolution of painful nodules or cysts.
• Extraction – manual removal of comedones performed by a dermatologist.
• Microneedling with topical agents – improves scar remodeling.

Lifestyle & Adjunct Measures

• Gentle skin‑cleansing twice daily with non‑comedogenic products.
• Avoid picking or squeezing lesions to prevent scarring.
• Limit exposure to oily cosmetics; choose “oil‑free” or “non‑comedogenic” labels.
• Maintain a balanced diet low in high‑glycemic foods; consider reducing dairy intake if you notice a flare.

Living with Acne Vulgaris

Managing acne goes beyond medication; psychological well‑being is equally important.

Daily skincare routine

1. Cleanse – use a mild, sulfate‑free cleanser; avoid scrubbing.
2. Treat – apply topical agents (e.g., benzoyl peroxide or retinoid) after the skin dries.
3. Moisturize – select a light, oil‑free moisturizer to prevent barrier disruption.
4. Sun protection – broad‑spectrum SPF 30+; some acne meds increase photosensitivity.

Psychosocial tips

• Join support groups or online forums (e.g., Acne Support Community on Reddit).
• Practice stress‑reduction techniques—mindfulness, yoga, or regular exercise.
• Consider counseling if acne triggers anxiety or depression; up to 40% of teens with severe acne report low self‑esteem (CDC, 2022).

Monitoring progress

Take photos every 4–6 weeks under consistent lighting to track improvement. Keep a treatment diary noting any side effects, flare triggers, and medication adherence.

Prevention

While you cannot completely prevent acne, several strategies lower the risk of new lesions or worsening.

• Wash pillowcases, phone screens, and hats weekly.
• Avoid heavy, occlusive cosmetics; opt for “non‑comedogenic” labels.
• Limit use of oily hair products that can migrate to the face.
• Stay hydrated and follow a diet rich in fruits, vegetables, whole grains, and lean protein.
• Manage stress through sleep hygiene (7‑9 hours/night) and regular physical activity.

Complications

If left untreated or improperly managed, acne can lead to:

• Permanent scarring – may require surgical or laser scar revision.
• Post‑inflammatory hyperpigmentation – especially in darker skin types; can persist for months.
• Psychological distress – depression, social withdrawal, or body‑image disorders.
• Secondary infection – bacterial overgrowth from picking can cause cellulitis.
• Medication side effects – e.g., isotretinoin‑related teratogenicity, liver toxicity, or mood changes; requires close monitoring.

When to Seek Emergency Care

---

**References** (accessed April 2026)

• Mayo Clinic. “Acne.” https://www.mayoclinic.org
• Centers for Disease Control and Prevention. “Acne.” https://www.cdc.gov
• National Institutes of Health. “Acne Treatment Guidelines.” 2023. NIAMS
• World Health Organization. “Skin diseases and mental health.” 2022. WHO
• American Academy of Dermatology. “Global Acne Grading System.” 2021. AAD
• J. Am. Acad. Dermatol. 2021;84(4):1033‑1042. “Genetic determinants of severe acne.”
• ClinicalTrials.gov. “Isotretinoin Pregnancy Prevention Program (iPLEDGE).” Updated 2024.

```